oxcarbazepine

Key facts

INN

oxcarbazepine

Brand

OXCARBAZEPINE

Route

ORAL

Formulation

TABLET, EXTENDED RELEASE

Originator

Amneal Pharmaceuticals

Related patents

patent

US 11896599

Modified release preparations containing oxcarbazepine and derivatives thereof

Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11166960

Modified release preparations containing oxcarbazepine and derivatives thereof

Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10220042

Modified release preparations containing oxcarbazepine and derivatives thereof

Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9855278

Modified release preparations containing oxcarbazepine and derivatives thereof

Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9370525

Modified release preparations containing oxcarbazepine and derivatives thereof

Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9351975

Modified release preparations containing oxcarbazepine and derivatives thereof

Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9119791

Modified release preparations containing oxcarbazepine and derivatives thereof

Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9119792

Modified release preparations containing oxcarbazepine and derivatives thereof

Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is oxcarbazepine?

oxcarbazepine (OXCARBAZEPINE), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for oxcarbazepine?

OXCARBAZEPINE is a marketed brand name for oxcarbazepine. Check FDA Drugs@FDA for the current US label holder.